pharmaphorum
FEBRUARY 3, 2022
India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. While the regulatory framework for cannabinoid products remains fragmented and hard to navigate around the world, Germany has emerged as an early-mover.
Fierce Healthcare
FEBRUARY 1, 2022
Kindbody hits unicorn status with Vios Fertility Institute acquisition, new leadership additions. rtorrence. Tue, 02/01/2022 - 17:13.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
FEBRUARY 3, 2022
A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.
Tria Health Blog
FEBRUARY 4, 2022
February 4th is National Wear Red Day. This day focuses on increasing awareness for women’s heart health. While most heart disease and stroke deaths are preventable, cardiovascular diseases continue to be the greatest health risk for women.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JANUARY 31, 2022
People with long-lasting symptoms of breathlessness after COVID-19 infection may have damage to their lungs that does not show up using routine diagnostic scans, according to a small UK study. The researchers from Oxford, Sheffield, Cardiff and Manchester universities used a new form of diagnostic that involves patients breathing in the inert gas xenon whilst undergoing an MRI scan, which allows them to gauge how well gases like oxygen are being transferred from the lungs to blood vessels.
Fierce Healthcare
FEBRUARY 3, 2022
Meditation app Calm buys Ripple Health Group to build out mental healthcare offerings. rtorrence. Thu, 02/03/2022 - 15:04.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
NICE
FEBRUARY 4, 2022
Following the announcement last year of a two-year collaboration agreement between NICE and the AHSN Network , I wanted to consider the alignment between the two organisations and specific ways this agreement looks to further strengthen the use of the best evidence-based healthcare in the NHS. NICE and the AHSN Network share the common purpose of identifying and accelerating the uptake of well-evidenced innovations into health and care services to improve quality, safety, outcomes and experience
pharmaphorum
FEBRUARY 1, 2022
The new BA.2 subvariant of Omicron is around 50% more transmissible than the original BA.1 strain, and there is somewhat conflicting evidence on its ability to evade the protection from vaccines, according to new studies. BA.2 is now the dominant strain of the COVID-19 virus in Denmark, and scientists from the country’s Statens Serum Institute (SSI) have compared the two subvariants in more than 8,500 households including almost 18,000 people.
Fierce Healthcare
FEBRUARY 2, 2022
HHS: Disparities in video telehealth use highlight key barriers to access. rking. Wed, 02/02/2022 - 13:45.
Outsourcing Pharma
JANUARY 31, 2022
The Stoneygate and Kidney Research UK Alport Research Hub aims to accelerate research and develop treatments for Alport syndrome, a rare genetic disorder.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Tutor
FEBRUARY 4, 2022
Pharmacy Bill: a Kaleidoscope. Dr. R. S. Thakur. Chief Editor, Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy, Bengaluru-560035. Email: drramsthakur@gmail.com. . admin. Fri, 02/04/2022 - 14:11. Tags. Articles.
pharmaphorum
JANUARY 30, 2022
2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. All told, the sector raised £4.5 billion ($6 billion) in public and private financings during the year, almost two-third (60%) up on the previous year, with £1.3 billion coming from initial public offerings (IPOs) on both sides of the Atlantic.
Fierce Healthcare
FEBRUARY 1, 2022
Unvaccinated 23 times more likely than boosted to be hospitalized during omicron wave. dmuoio. Tue, 02/01/2022 - 16:13.
Outsourcing Pharma
JANUARY 31, 2022
Biogen releases further details on how its Phase 4 post-marketing confirmatory study for Alzheimerâs drug, Aduhelm, will run: including increased enrolment and enhanced efforts to encourage diversity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Mirror
FEBRUARY 4, 2022
Rockville, Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced its role as a Data Coordinating Center on a team whose work has accelerated pediatric COVID-19 research through the Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POP02).
pharmaphorum
FEBRUARY 4, 2022
The approval of Novavax’ COVID-19 vaccine in Great Britain could help the country save a “considerable amount of money” if it is used in future booster campaigns, according to the former chair of UK Vaccine Taskforce. Dr Clive Dix said that Nuvaxovid has excellent clinical data and – as a it has good stability at fridge temperatures – could be easily rolled out with the flu vaccine next winter, and should “replace the need to buy more Pfizer and Moderna vaccine.” Nu
Fierce Healthcare
FEBRUARY 1, 2022
Healthcare data breaches hit all-time high in 2021, impacting 45M people. hlandi. Tue, 02/01/2022 - 16:25.
Outsourcing Pharma
FEBRUARY 1, 2022
During OSPâs exclusive February 23 webinar Rare and Orphan Diseases, leading expertswill lend their unique experience and expertise to the important topic.
Lifewell Rx Pharmacy
FEBRUARY 3, 2022
Antibiotics are medications that are given to someone with infection. It is used to destroy or slow down bacterial growth and prevent infections from getting any more complicated. Usually, any pharmacy carrying antibiotics would require you to show a doctor’s prescription before you can purchase them. It is a powerful medication but should be used with caution.
pharmaphorum
FEBRUARY 3, 2022
Novartis chief executive Vas Narasimhan has downplayed any chances of swift decision on the future of its generics business Sandoz, saying that a decision on the possible sale of the unit may not come until the last quarter of the year. The comments came despite rumours of another private equity bid for Sandoz, with Bloomberg saying it had got wind of a $25 billion combined bid from investment groups Blackstone and Carlyle, with others including Advent International, Hellman & Friedman and K
Fierce Healthcare
FEBRUARY 3, 2022
From Amazon to New Balance, consumer brand execs bring 'outsider' perspective to healthcare. agliadkovskaya. Thu, 02/03/2022 - 15:26.
Outsourcing Pharma
FEBRUARY 3, 2022
The oncology centerâs Marie-JosÃe and Henry R. Kravis Cancer Ecosystems Project is intended to elevate the next generation of preclinical cancer research.
Pharma Mirror
FEBRUARY 3, 2022
Everybody knows that life as a caretaker can get rough sometimes, but it also comes with its fair share of benefits. In this article, we aim to highlight some of the long-term benefits of wearing scrubs to work, day in and day out. Being youthful at heart and work Depending on the scrub policy you have at your place of work, charcoal grey scrubs can add a completely new layer to your professional attire.
pharmaphorum
FEBRUARY 3, 2022
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at dealing with sudden stress and turning it into positive energy. We’ve all been there: stomach revolting, heart pounding, hands moist.
Fierce Healthcare
FEBRUARY 3, 2022
Butterfly Network, Ambra Health team up to streamline medical imaging integration. agliadkovskaya. Thu, 02/03/2022 - 16:18.
Outsourcing Pharma
JANUARY 31, 2022
The pharma firm has announced the agency has approved the companyâs investigational new drug application for its Phase II trial of pemvidutide for obesity.
Pharma Mirror
FEBRUARY 2, 2022
Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the Biologics market, with a particular focus on drug substance manufacturing of novel ATMPs.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
Fierce Healthcare
FEBRUARY 2, 2022
HealthRhythms lands UCHealth partnership, $11M investment to scale up AI-based mental health app. hlandi. Wed, 02/02/2022 - 15:39.
NICE
FEBRUARY 2, 2022
From sensor-enabled glasses that facilitate self-management for major depression to devices that measure muscle performance to improve a person’s gait, NICE has worked in partnership with Innovate UK and the University of Manchester to support 16 digital health technology (DHT) developers over the last three years as part of the Digital Health Technology Catalyst.
McCreadie Group
FEBRUARY 1, 2022
February 2022 | Vincent Puglia Clinical trial technology is typically a constellation of systems and devices that exists in a continuum with the subject at its center and cocentric rings extending out to sites, partners, providers, CROs, and sponsors. A good clinical trial system (sometimes called “eClinical system”) will enhance efficiency and speed during the.
pharmaphorum
FEBRUARY 4, 2022
Eli Lilly has backed away from plans to file Alzheimer’s drug donanemab in the first quarter of this year, saying the proposal to limit reimbursement of Biogen’s first-to-market Aduhelm has made going down the accelerated approval route all-but pointless. The company has planned to filed for speedy approval of donanemab based on the results of its TRAILBLZAR-ALZ study, in the hope of being allowed by the FDA to make the drug available to patients while its confirmatory TRAILBLAZER-AZ
Fierce Healthcare
FEBRUARY 2, 2022
Warren calls for end to Direct Contracting, reforms to Medicare Advantage risk adjustment. rking. Wed, 02/02/2022 - 16:57.
Policy Prescription
JANUARY 31, 2022
This post should serve as the beginning of a serious inquiry into the failure of U.S. state boards of pharmacy to properly regulate pharmacies that irresponsibly and too often illegally profited from opioid drug sales to patients. Sociologist Elizabeth Chiarello writes , “Boards have a duty to protect the public, but because they are mostly comprised of professionals whose common interests may conflict with those of the public, their ability to do so is questionable.
Expert insights. Personalized for you.
118 
Let's personalize your content